BRPI0817973A2 - derivados de nicotinamida, o respectivo preparo e a respectiva aplicação em terapêutica - Google Patents
derivados de nicotinamida, o respectivo preparo e a respectiva aplicação em terapêuticaInfo
- Publication number
- BRPI0817973A2 BRPI0817973A2 BRPI0817973-5A BRPI0817973A BRPI0817973A2 BR PI0817973 A2 BRPI0817973 A2 BR PI0817973A2 BR PI0817973 A BRPI0817973 A BR PI0817973A BR PI0817973 A2 BRPI0817973 A2 BR PI0817973A2
- Authority
- BR
- Brazil
- Prior art keywords
- group
- preparation
- hydrogen atom
- therapeutic
- nicotinamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Abstract
derivados de nicotinamida, sua preparação e sua aplicação em terapêutica a presente invenção refere-se a um composto de fórmula (1): em que: . a representa um grupo -nr1 r'1 ou (c1-c6)alcóxi; z e z' representam respectivamente n e ch; n e cf; n e n; ch e ch; ch e n; l representa um grupo -ch=ch- ou -chzchz- ou -(chz)n-y-,. r1 e r'1 são tais que: (i) r1 representa: - um átomo de hidrogênio; - um grupo arila eventualmente substituído por um ou vários átomos de halogênio; - um grupo heteroarila; - um grupo (c3-cs)cicloalquila; -um grupo (c1-cs) alquila, e r'1 representa um átomo de hidrogênio ou um grupo (c1-c6) alquila; ou (11) r1 e r'1 forma juntos com o átomo de nitrogênio ao qual são ligados um grupo heterocicloalquila; rz representa um grupo -q-~; q representa um átomo de oxigênio ou o grupo -nh-; ~ representa: - um átomo de hidrogênio; - um grupo heteroarila; - um grupo (c3-cs) cicloalquila; - um grupo (c1-c6) alquila, eventualmente substituído; r3 representa pelo menos um substituinte do núcleo piridina
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0706799 | 2007-09-28 | ||
FR0706799A FR2921657A1 (fr) | 2007-09-28 | 2007-09-28 | Derives de nicotinamide, leur preparation et leur application en therapeutique |
PCT/FR2008/001338 WO2009074749A2 (fr) | 2007-09-28 | 2008-09-26 | Dérives de nicotinamide. leur préparation et leur application en thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0817973A2 true BRPI0817973A2 (pt) | 2019-04-09 |
Family
ID=39356668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0817973-5A BRPI0817973A2 (pt) | 2007-09-28 | 2008-09-26 | derivados de nicotinamida, o respectivo preparo e a respectiva aplicação em terapêutica |
Country Status (19)
Country | Link |
---|---|
US (1) | US20100222319A1 (pt) |
EP (1) | EP2205566A2 (pt) |
JP (1) | JP2010540504A (pt) |
KR (1) | KR20100065165A (pt) |
CN (1) | CN101808996A (pt) |
AR (1) | AR066171A1 (pt) |
AU (1) | AU2008334457A1 (pt) |
BR (1) | BRPI0817973A2 (pt) |
CA (1) | CA2700559A1 (pt) |
CL (1) | CL2008002893A1 (pt) |
FR (1) | FR2921657A1 (pt) |
IL (1) | IL204663A0 (pt) |
MX (1) | MX2010003445A (pt) |
PA (1) | PA8797301A1 (pt) |
PE (1) | PE20091033A1 (pt) |
RU (1) | RU2010116765A (pt) |
TW (1) | TW200918056A (pt) |
UY (1) | UY31367A1 (pt) |
WO (1) | WO2009074749A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2404919T1 (sl) | 2005-11-08 | 2013-12-31 | Vertex Pharmaceuticals Incorporated | Heterocikliäśna spojina uporabna kot modulator za prenaĺ alce z atp-vezavno kaseto |
CA2686838C (en) | 2007-05-09 | 2017-03-14 | Vertex Pharmaceuticals Incorporated | Modulators of cftr |
CA2706920C (en) | 2007-12-07 | 2018-02-13 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
PT2639222T (pt) * | 2007-12-07 | 2016-11-01 | Vertex Pharma | Processo de produção de ácidos cicloalquilcarboxamido-piridina-benzoicos |
ES2647531T3 (es) | 2008-02-28 | 2017-12-22 | Vertex Pharmaceuticals Incorporated | Derivados de heteroarilo como moduladores de CFTR |
FR2943670B1 (fr) * | 2009-03-24 | 2011-05-06 | Sanofi Aventis | Derives anticancereux,leur preparation et leur application en therapeutique |
FR2943675A1 (fr) * | 2009-03-24 | 2010-10-01 | Sanofi Aventis | Composes anticancereux, leur preparation et leur application en therapeutique |
FR2943669B1 (fr) * | 2009-03-24 | 2011-05-06 | Sanofi Aventis | Derives de nicotinamide,leur preparation et leur application en therapeutique |
WO2010144647A1 (en) * | 2009-06-12 | 2010-12-16 | Bristol-Myers Squibb Company | Nicotinamide compounds useful as kinase modulators |
CA2791680A1 (en) * | 2010-03-01 | 2011-09-09 | Myrexis, Inc. | Compounds and therapeutic uses thereof |
US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
HRP20211752T1 (hr) | 2010-04-07 | 2022-02-18 | Vertex Pharmaceuticals Incorporated | Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena |
US8827372B2 (en) | 2010-07-07 | 2014-09-09 | Frontis Corp. | Blowing system |
FR2965263A1 (fr) * | 2010-09-24 | 2012-03-30 | Sanofi Aventis | Derives de thienopyridine nicotinamide, leur preparation et leur application en therapeutique |
US9169246B2 (en) | 2011-09-26 | 2015-10-27 | Sanofi | Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
CN103012397B (zh) * | 2011-09-26 | 2017-03-01 | 赛诺菲 | 吡唑并喹啉酮衍生物、其制备方法及其治疗用途 |
EP2573073B1 (en) * | 2011-09-26 | 2014-10-22 | Sanofi | Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
PL3068392T3 (pl) | 2013-11-12 | 2021-07-19 | Vertex Pharmaceuticals Incorporated | Proces wytwarzania kompozycji farmaceutycznych do leczenia chorób, w których pośredniczy cftr |
CN103804270B (zh) * | 2014-01-23 | 2016-06-22 | 中国药科大学 | 5-(4-甲脒基苄氧基)色氨酸衍生物、其制法及应用 |
JP6494757B2 (ja) | 2014-11-18 | 2019-04-03 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | ハイスループット試験高速液体クロマトグラフィーを行うプロセス |
WO2017219935A1 (zh) | 2016-06-22 | 2017-12-28 | 复旦大学 | 联芳基脲类衍生物或其盐及其制备方法和用途 |
CN107522641B (zh) * | 2016-06-22 | 2020-05-05 | 复旦大学 | 联芳基脲类衍生物或其盐及其制备方法和用途 |
CN112312899A (zh) * | 2018-05-04 | 2021-02-02 | 治疗方案股份有限公司 | 靶向癌症干细胞的癌症治疗 |
CN110396065A (zh) * | 2019-06-25 | 2019-11-01 | 南京普锐达医药科技有限公司 | 一种2,4-二氯-5-嘧啶甲酰氯的合成方法 |
CN114929672A (zh) * | 2019-11-06 | 2022-08-19 | 治疗方案股份有限公司 | 靶向癌症干细胞的癌症治疗 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4301110A1 (de) * | 1993-01-18 | 1994-07-21 | Bayer Ag | Verfahren zur Herstellung von 2-Amino-5-aminomethyl-pyridin |
ES2249059T3 (es) * | 1998-12-16 | 2006-03-16 | Bayer Healthcare Ag | Nuevos compuestos de bifenilo y analogos de bifenilo como antagonista de integrina. |
DE10063008A1 (de) * | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
US20040067985A1 (en) * | 2002-10-04 | 2004-04-08 | Fortuna Haviv | Method of inhibiting angiogenesis |
US20080312192A1 (en) * | 2003-11-28 | 2008-12-18 | Guido Bold | Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases |
US20060216288A1 (en) * | 2005-03-22 | 2006-09-28 | Amgen Inc | Combinations for the treatment of cancer |
-
2007
- 2007-09-28 FR FR0706799A patent/FR2921657A1/fr not_active Withdrawn
-
2008
- 2008-09-24 TW TW097136703A patent/TW200918056A/zh unknown
- 2008-09-26 CL CL2008002893A patent/CL2008002893A1/es unknown
- 2008-09-26 EP EP08859496A patent/EP2205566A2/fr not_active Withdrawn
- 2008-09-26 CN CN200880109332A patent/CN101808996A/zh active Pending
- 2008-09-26 MX MX2010003445A patent/MX2010003445A/es not_active Application Discontinuation
- 2008-09-26 WO PCT/FR2008/001338 patent/WO2009074749A2/fr active Application Filing
- 2008-09-26 KR KR1020107006595A patent/KR20100065165A/ko not_active Application Discontinuation
- 2008-09-26 CA CA2700559A patent/CA2700559A1/fr not_active Abandoned
- 2008-09-26 AR ARP080104193A patent/AR066171A1/es unknown
- 2008-09-26 BR BRPI0817973-5A patent/BRPI0817973A2/pt not_active IP Right Cessation
- 2008-09-26 PE PE2008001687A patent/PE20091033A1/es not_active Application Discontinuation
- 2008-09-26 AU AU2008334457A patent/AU2008334457A1/en not_active Abandoned
- 2008-09-26 PA PA20088797301A patent/PA8797301A1/es unknown
- 2008-09-26 JP JP2010526335A patent/JP2010540504A/ja not_active Withdrawn
- 2008-09-26 UY UY31367A patent/UY31367A1/es not_active Application Discontinuation
- 2008-09-26 RU RU2010116765/04A patent/RU2010116765A/ru not_active Application Discontinuation
-
2010
- 2010-03-22 IL IL204663A patent/IL204663A0/en unknown
- 2010-03-26 US US12/732,749 patent/US20100222319A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2010540504A (ja) | 2010-12-24 |
UY31367A1 (es) | 2009-04-30 |
TW200918056A (en) | 2009-05-01 |
US20100222319A1 (en) | 2010-09-02 |
AU2008334457A1 (en) | 2009-06-18 |
RU2010116765A (ru) | 2011-11-27 |
CN101808996A (zh) | 2010-08-18 |
PA8797301A1 (es) | 2009-05-15 |
KR20100065165A (ko) | 2010-06-15 |
EP2205566A2 (fr) | 2010-07-14 |
PE20091033A1 (es) | 2009-08-17 |
IL204663A0 (en) | 2010-11-30 |
WO2009074749A3 (fr) | 2009-08-20 |
CL2008002893A1 (es) | 2009-10-16 |
MX2010003445A (es) | 2010-04-27 |
AR066171A1 (es) | 2009-07-29 |
WO2009074749A2 (fr) | 2009-06-18 |
CA2700559A1 (fr) | 2009-06-18 |
FR2921657A1 (fr) | 2009-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0817973A2 (pt) | derivados de nicotinamida, o respectivo preparo e a respectiva aplicação em terapêutica | |
MX2009011532A (es) | Derivados de piridina sustituidos por un anillo heterociclico y grupo fosfonoamino, y agente anti-fungal que contiene los mismos. | |
MX2009002802A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparacion y su aplicacion en terapeutica. | |
DK1414302T3 (da) | 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe | |
MY153393A (en) | Amino nicotinic and isonicotinic acid derivatives as dhodh as inhibitors | |
EA201071111A1 (ru) | ПОЛИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 6-ГЕТЕРОАРИЛИМИДАЗО[1,2-a]ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ | |
IN2012DN00573A (pt) | ||
MY160443A (en) | Nitrogen-containing heterocyclic compound and agricultural fungicide | |
DK1622879T3 (da) | Pyrimidinforbindelser og skadedyrsbekæmpelsespræparater indeholdende disse | |
BRPI0606845A2 (pt) | derivados de (1,5-difenil-1h-pirazol-3-il)oxadiazol, o respectivo preparo e a respectiva aplicação em terapêutica | |
MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
NZ596615A (en) | Substituted isoquinoline derivative | |
BRPI1007456A2 (pt) | derivados de azaespiranil-alquilcarbamatos de compostos heterocíclicos com 5 membros, o respectivo preparo e a respectiva aplicação em terapêutica | |
MX2009011212A (es) | Derivados de triazolopiridina carboxamida y triazolopirimidina carboxamida, su preparacion y su aplicacion terapeutica. | |
WO2008155668A3 (en) | Heteroarylamide pyrimidone compounds | |
EA201170099A1 (ru) | Замещенные пиримидин-4-оновые производные | |
MY168283A (en) | Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy | |
WO2009118473A3 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
MX2010008361A (es) | Derivados de arilamida oxazepinopirimidona sustituidos. | |
WO2008136444A1 (ja) | 縮合複素環誘導体 | |
CO6321168A2 (es) | Nuevos derivados de 2-amidotiadiazol | |
EA200971063A1 (ru) | Ариламидпиримидоновые соединения | |
EA201070010A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
MX2010010471A (es) | Derivado de tetrahidroisoquinolina novedoso. | |
NO20072454L (no) | Pyridinderivater, fremstillingen og den terapeutiske anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A, 8A, 9A E 10A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2519 DE 16-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |